Japanese Nobel laureate keen to use AI in iPS cell treatment

Japanese Nobel Prize winner Shinya Yamanaka speaks in an interview with Kyodo News in Kyoto, western Japan, on June 7, 2016. Yamanaka, a Kyoto University professor, said he sees potential for tapping artificial intelligence to more quickly and accurately check the safety of induced pluripotent stem cells in regenerative medicine. (Kyodo) ==Kyodo

Sample
PDF Preview

Product Code
ILEA000090921

Registered date
2016/7/27 17:17:29

Credit
Kyodo / Kyodo News Images

Media source
2016 Kyodo News

Media size
2588 × 3731 pixel

Resolution
240 dpi

Deployment size
788.38(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

World's 1st trial of drug developed from iPS cells to begin

Junya Toguchida, professor at Kyoto University, speaks at a press conference in Kyoto on Aug. 1, 2017, announcing that his team will begin the world's first clinical trial of a drug developed from induced pluripotent stem cells to treat fibrodysplasia ossificans progressiva, a rare bone disease. (Kyodo) ==Kyodo

Nobel Prize winner Osumi says research environment deteriorated

Nobel laureate in physiology or medicine, Yoshinori Osumi, meets with reporters after giving a lecture at the Liberal Democratic Party headquarters in Tokyo on Oct. 12, 2016. The 71-year-old professor emeritus at the Tokyo Institute of Technology showed concern that the research environment of Japanese universities has deteriorated. (Kyodo) ==Kyodo

Japanese Nobel laureate keen to use AI in iPS cell treatment

Japanese Nobel Prize winner Shinya Yamanaka speaks in an interview with Kyodo News in Kyoto, western Japan, on June 7, 2016. Yamanaka, a Kyoto University professor, said he sees potential for tapping artificial intelligence to more quickly and accurately check the safety of induced pluripotent stem cells in regenerative medicine. (Kyodo) ==Kyodo